Sleep product firms' results benefit from expanding markets
This article was originally published in Clinica
Beckman Coulter's sales growth came from positive currency effects, new product contributions and general growth in hardware and installation business. Clinical diagnostics grew by 17%, and the new UniCel Dxl 800 Access immunoassay system for high-volume labs is expected to provide continuing momentum. The company's net income was adversely affected by restructuring charges associated with the creation of the biomedical research division, among other things.